Functional Visual Improvement After Cataract Surgery in Eyes With Age-Related Macular Degeneration: Results of the Ophthalmic Surgical Outcomes Data Project

2015 ◽  
Vol 56 (4) ◽  
pp. 2536 ◽  
Author(s):  
Michael V. Stock ◽  
David E. Vollman ◽  
Elizabeth F. Baze ◽  
Amy S. Chomsky ◽  
Mary K. Daly ◽  
...  
2022 ◽  
Vol 7 (4) ◽  
pp. 655-658
Author(s):  
Deepika Joshi ◽  
Sourav Shristi

To determine whether patients with Age related macular degeneration (ARMD) benefit from cataract surgery in terms of best corrected visual acuity (BCVA) and to assess impact of surgery on progression of ARMD.: A prospective study was carried out of patients with and without ARMD undergoing cataract surgery at our department. Patients were divided into two groups- Group A (cases) with ARMD and Group B (controls) without ARMD and other retinal pathology. BCVA of cases was recorded on day 1, day 14, 1 month and 1/month and compared to that of controls.: BCVA significantly improved but markedly less than that experienced by control eyes. No increased incidence in progression to wet form of ARMD. Cataract surgery is safe in ARMD patients with no evidence of increased complications or rates of disease advancement.


2003 ◽  
Vol 29 (4) ◽  
pp. 686-693 ◽  
Author(s):  
Ana Maria Armbrecht ◽  
Catherine Findlay ◽  
Peter Alan Aspinall ◽  
Adrian Robert Hill ◽  
Baljean Dhillon

2020 ◽  
Author(s):  
Inger Westborg ◽  
Susanne Albrecht ◽  
Elisabet Granstam ◽  
Niklas Karlsson ◽  
Maria Kugelberg ◽  
...  

Ophthalmology ◽  
2009 ◽  
Vol 116 (2) ◽  
pp. 297-303 ◽  
Author(s):  
Emily Y. Chew ◽  
Robert D. Sperduto ◽  
Roy C. Milton ◽  
Traci E. Clemons ◽  
Gary R. Gensler ◽  
...  

2016 ◽  
Vol 93 (2) ◽  
pp. 165-172 ◽  
Author(s):  
Yingyan Ma ◽  
Jiannan Huang ◽  
Bijun Zhu ◽  
Qian Sun ◽  
Yuyu Miao ◽  
...  

2015 ◽  
Vol 08 (02) ◽  
pp. 116
Author(s):  
Charles C Wykoff ◽  

End-stage age-related macular degeneration (AMD) affects approximately 1.8 million Americans and limits older adults’ ability to perform activities of daily living. No current pharmaceutical options exist for visual improvement in these patients. The telescope implant is the only Food and Drug Administration approved intraocular device for visual rehabilitation in end-stage AMD patients, with either bilateral geographic atrophy or disciform scarring, who are phakic (in at least one eye) with best spectacle-corrected visual acuity of 20/160–20/800 or worse in both eyes.


Sign in / Sign up

Export Citation Format

Share Document